Search results for: 'Life Science Tools and Diagnostics'

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

This research service provides an analysis of various aspects of the molecular diagnostics market in Europe for the years 2007 - 2015. The market has been divided into four segments: infectious diseases, genetic diseases, oncology and pharmacogenomics. The market has been covered segment wise, as well as geography wise, covering seven countries and...

The United Kingdom (UK) medical technology (MedTech) market is experiencing a transformational phase. Although it achieved steady growth up to 2019 and was infused with investments as part of the UK Life Sciences Sector Deal, market and regulatory challenges persist. In this research study, Frost & Sullivan analyzes the UK MedTech market landscape ...

This RS analyses the trends in the global machine tools and cutting tools market, particularly the trend of increased investment in automobile, aerospace and defence, and civil construction sectors in Brazil, Russia, India, and China (BRIC). The driving forces, such as the exploration of new oil and gas fields and the expansion of the mining indust...

15 Apr 2025  |  Europe  |  Market Research

CO2 Emissions Life Cycle in the Hydrogen ICE Truck Sector, EU, 2024–2040

Clean H2 Production Sources and the Adoption of H2 ICE as an Intermediate Solution Will Drive Transformational Growth by Significantly Reducing CO2 Emissions

Infographics

×

In this study, Frost & Sullivan offers a comprehensive exploration of the carbon dioxide (CO2) trail of a hydrogen ICE truck (H2 ICE) by investigating the carbon emission implications, focusing on hydrogen as a prospective fuel for the trucking industry in 3 countries within the European Union—France, Germany, and Spain. The analysis begins with th...

This research service evaluates the Western European cancer IVD market for Germany, the United Kingdom, Italy, Spain, France, Benelux and Scandinavia from 2010 to 2019. Beginning with an overview of the main market metrics and trends, the study identifies the key market drivers and restraints, evaluates ongoing competitive trends with detailed mark...

The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...

The increase in HIV awareness among people has led to the demand for effective diagnostic products and solutions. As a result, some new products based on NAT technology and non-NAT technology platforms are being developed. This research service analyses the HIV diagnostics market in Europe, particularly, HIV NAT diagnostics and HIV Immunodiagnostic...

The aim of this research service is to thoroughly assess and analyse the in vitro diagnostics market in Western European countries and provide strategic recommendations and conclusions for the success of market participants. This study provides an understanding of the key segments (immunochemistry, microbiology, molecular diagnostics, POCT, SMBG, t...